Average Co-Inventor Count = 3.49
ph-index = 20
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck + Co., Inc. (74 from 4,770 patents)
2. Novartis Ag (22 from 3,923 patents)
3. The Salk Institute for Biological Studies (3 from 576 patents)
4. Mitobridge, Inc. (3 from 20 patents)
5. Merck Sharp + Dohme Corp. (2 from 2,405 patents)
6. Eisai R&d Management Co., Ltd. (2 from 527 patents)
7. Other (1 from 832,680 patents)
8. Synaptic Pharmaceutical Corporation (1 from 126 patents)
104 patents:
1. 11420934 - PPAR agonists
2. RE49080 - Glycoside derivatives and uses thereof
3. 10851065 - Tetrasubstituted alkene compounds and their use
4. 10550071 - PPAR agonists
5. 10011599 - Compounds and compositions as inhibitors of MEK
6. 9938234 - PPAR agonists
7. 9895389 - Glycoside derivatives and uses thereof
8. 9796683 - Tetrasubstituted alkene compounds and their use
9. 9629836 - Compounds and compositions as inhibitors of MEK
10. 9624192 - Carbamate/urea derivatives
11. 9339501 - 17a-hydroxylase/C17,20-lyase inhibitors
12. 9273026 - Carbamate/urea derivatives
13. 9227969 - Compounds and compositions as inhibitors of MEK
14. 9051326 - Pyrazoline derivatives and their use as selective androgen receptor modulators
15. 9034874 - Carbamate/urea derivatives